
Low-positive CMV IgG serostatus before allogeneic hematopoietic cell transplantation is not associated with increased CMV reactivation risk
Cytomegalovirus (CMV) remains a major cause of morbidity after allogeneic hematopoietic cell transplantation (HCT), with recipient serostatus guiding CMV risk stratification and the use of








